Goldman Sachs upgrades General Electric Co. (GE) to Buy
Goldman Sachs upgrades General Electric Co. from Neutral to Buy with a $15 price target.
Goldman Sachs upgraded Johnson & Johnson from Neutral to Buy, while downgrading Bristol-Myers Squibb Co..